Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Teeka Tan finds Kruger

This article was originally published in The Rose Sheet

Executive Summary

Boca Raton, Fla.-based firm has licensed postcard and souvenir vender Kruger to distribute its suncare products in the coastal Carolina region, company announces Nov. 27. Myrtle Beach, S.C.-based Kruger will have the right to distribute the products for one year. The deal means greater exposure for Teeka Tan and Safe Sea lines in the region, including Myrtle Beach and other vacation destinations, firm notes. The items are currently sold in drug stores, supermarkets, gift shops and other mass retailers. Teeka Tan and Safe Sea are the only skincare lines on the market that protect against jellyfish and sea lice stings, Teeka Tan claims...

You may also be interested in...



Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification

Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014395

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel